Citation: British Journal of Dermatology. 185(3):654-655, 2021 09.; .Journal: The British journal of dermatology.Published: 2021; ; ; ISSN: 0007-0963.Full author list: Deng M; Hussain A; Pakhchanian H; Raiker R.UI/PMID: 33837520.Subject(s): *COVID-19 | *Skin Neoplasms | Humans | Risk Factors | SARS-CoV-2Institution(s): MedStar Washington Hospital CenterDepartment(s): Dermatology | Dermatology ResidencyActivity type: Journal Article.Medline article type(s): LetterOnline resources: Click here to access onlineDigital Object Identifier: https://dx.doi.org/10.1111/bjd.20386 (Click here)Abbreviated citation: Br J Dermatol. 185(3):654-655, 2021 09; .Abstract: The effect of skin cancer diagnosis on the risk of adverse outcomes from COVID-19 remains unknown. Few studies have shown cancer patients with COVID-19 have higher rates of mortality and hospitalizations compared to those without cancer, perhaps due to a combination of delayed diagnosis and pre-existing comorbidities from chemotherapy and radiation treatments.1. Copyright This article is protected by copyright. All rights reserved.